EUVIMEDDescoperă EUVIMED
Open access

Identification of Potential Vaccine Candidates Against SARS-CoV-2 to Fight COVID-19: Reverse Vaccinology Approach

Ekta Gupta iD, Rupesh Kumar Mishra iD, Ravi Ranjan Kumar Niraj iD

JMIR Bioinformatics and Biotechnology · 2022

DOI: 10.2196/32401 ↗

At a glance

Journal article in JMIR Bioinformatics and Biotechnology, 2022. Written by Ekta Gupta and 2 co-authors. Institution: Dr. B. Lal Institute of Biotechnology Jaipur India. Cited 6 times so far (Crossref); 41 references. The full text is freely available in PubMed Central.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background

The recent emergence of COVID-19 has caused an immense global public health crisis. The etiological agent of COVID-19 is the novel coronavirus SARS-CoV-2. More research in the field of developing effective vaccines against this emergent viral disease is indeed a need of the hour.

Objective

The aim of this study was to identify effective vaccine candidates that can offer a new milestone in the battle against COVID-19.

Methods

We used a reverse vaccinology approach to explore the SARS-CoV-2 genome among strains prominent in India. Epitopes were predicted and then molecular docking and simulation were used to verify the molecular interaction of the candidate antigenic peptide with corresponding amino acid residues of the host protein.

Results

A promising antigenic peptide, GVYFASTEK, from the surface glycoprotein of SARS-CoV-2 (protein accession number QIA98583.1) was predicted to interact with the human major histocompatibility complex (MHC) class I human leukocyte antigen (HLA)-A*11-01 allele, showing up to 90% conservancy and a high antigenicity value. After vigorous analysis, this peptide was predicted to be a suitable epitope capable of inducing a strong cell-mediated immune response against SARS-CoV-2.

Conclusions

These results could facilitate selecting SARS-CoV-2 epitopes for vaccine production pipelines in the immediate future. This novel research will certainly pave the way for a fast, reliable, and effective platform to provide a timely countermeasure against this dangerous virus responsible for the COVID-19 pandemic.

Subjects

Author keywords

COVID-19SARS-CoV-2antigenbiochemistrygeneticsimmunologymolecular dockingmolecular dynamics simulationpeptidereverse vaccinologysimulationvaccinevaccine candidatesvirus

Authors and institutions

  • Dr. B. Lal Institute of Biotechnology Jaipur India.
  • Amity University Rajasthan Jaipur India.

ORCID profiles: Ekta Gupta, Rupesh Kumar Mishra, Ravi Ranjan Kumar Niraj

Cite

APA

Gupta, E., Mishra, R. K., & Kumar Niraj, R. R. (2022). Identification of Potential Vaccine Candidates Against SARS-CoV-2 to Fight COVID-19: Reverse Vaccinology Approach. JMIR Bioinformatics and Biotechnology. https://doi.org/10.2196/32401

Vancouver

Gupta E, Mishra RK, Kumar Niraj RR. Identification of Potential Vaccine Candidates Against SARS-CoV-2 to Fight COVID-19: Reverse Vaccinology Approach. JMIR Bioinformatics and Biotechnology. 2022. doi:10.2196/32401

BibTeX
@article{Gupta2022,
  author = {Gupta, Ekta and Mishra, Rupesh Kumar and Kumar Niraj, Ravi Ranjan},
  title = {Identification of Potential Vaccine Candidates Against SARS-CoV-2 to Fight COVID-19: Reverse Vaccinology Approach},
  journal = {JMIR Bioinformatics and Biotechnology},
  year = {2022},
  doi = {10.2196/32401}
}
Start for free →